Densan Co., Ltd.
Densan Co., Ltd. (3640.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Densan Co., Ltd. (3640.T), covering cash flow, earnings, and balance sheets.
Densan Co., Ltd. (3640.T) Income Statement & Financial Overview
View the income breakdown for Densan Co., Ltd. 3640.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.22B | $4.23B | $3.71B | $3.59B |
| Cost of Revenue | $4.58B | $2.79B | $2.47B | $2.40B |
| Gross Profit | $2.63B | $1.44B | $1.24B | $1.18B |
| Gross Profit Ratio | $0.36 | $0.34 | $0.33 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $900.65M | $941.00M | $1.05B | $1.08B |
| Operating Expenses | $900.65M | $941.00M | $1.05B | $1.08B |
| Total Costs & Expenses | $5.49B | $3.74B | $3.52B | $3.48B |
| Interest Income | $1.09M | $112000.00 | $295000.00 | $62000.00 |
| Interest Expense | $5.13M | $4.57M | $4.22M | $3.94M |
| Depreciation & Amortization | $329.05M | $197.00M | $190.13M | $197.00M |
| EBITDA | $2.06B | $692.00M | $380.40M | $302.00M |
| EBITDA Ratio | $0.29 | $0.16 | $0.10 | $0.08 |
| Operating Income | $1.73B | $495.00M | $185.30M | $104.00M |
| Operating Income Ratio | $0.24 | $0.12 | $0.05 | $0.03 |
| Other Income/Expenses (Net) | -$3.83M | $4.00M | $755000.00 | $4.00M |
| Income Before Tax | $1.73B | $499.00M | $186.06M | $108.00M |
| Income Before Tax Ratio | $0.24 | $0.12 | $0.05 | $0.03 |
| Income Tax Expense | $473.36M | $138.00M | $36.08M | $33.00M |
| Net Income | $1.26B | $361.00M | $149.97M | $75.00M |
| Net Income Ratio | $0.17 | $0.09 | $0.04 | $0.02 |
| EPS | $216.17 | $62.06 | $25.86 | $12.95 |
| Diluted EPS | $215.37 | $62.11 | $25.86 | $12.95 |
| Weighted Avg Shares Outstanding | $5.83M | $5.82M | $5.80M | $5.79M |
| Weighted Avg Shares Outstanding (Diluted) | $5.83M | $5.81M | $5.80M | $5.79M |
Over the last four quarters, Densan Co., Ltd.'s revenue moved from $3.59B in Q1 2024 to $7.22B in Q4 2024. Operating income in Q4 2024 was $1.73B, with a strong operating margin of 24%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Densan Co., Ltd. remained robust at $2.06B, reflecting operational efficiency. Net income rose to $1.26B, with an EPS of $216.17. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan